← Leaderboards
Jifeng Zhang
Applied Stemcell, Inc.
$7,530,171
Attributed
$7,530,171
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.7M · FY2016–25$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,530,171 · 5
By mechanism
R01$4,972,139 · 2
R42$2,108,514 · 1
R41$449,518 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Genes”
- David Heimbrook · Leidos Biomedical Research, Inc.$413,811,031
- Richard A Gibbs · Baylor College Of Medicine$338,750,128
- Barton F Haynes · Duke University$304,076,400
- Stacey Gabriel · Massachusetts Institute Of Technology$241,252,013
- Eric S Lander · Whitehead Institute For Biomedical Res$211,825,987
- Richard K. Wilson · Washington University$195,881,965
Research focus
GenesIn VivoReportingCellsMouse ModelPathway InteractionsMediatingKnock-OutPharmaceutical PreparationsKnockout MiceIn VitroAtherosclerosisInsightMolecularInflammationGene ExpressionFunctional DisorderAortaAttenuatedCardiovascular SystemHomeostasisDiabetes MellitusBlood VesselsFamily
Grant awards (15)
BAF60c and abdominal aortic aneurysm$543,752
R01 · FY2025 · HL · contact PI
BAF60c and abdominal aortic aneurysm$532,877
R01 · FY2024 · HL · contact PI
Novel methods to improve nuclease mediated homologous recombination$940,327
R42 · FY2023 · GM · contact PI
BAF60c and abdominal aortic aneurysm$543,752
R01 · FY2023 · HL · contact PI
Novel methods to improve nuclease mediated homologous recombination$854,843
R42 · FY2022 · GM · contact PI
BAF60c and abdominal aortic aneurysm$543,752
R01 · FY2022 · HL · contact PI
Novel methods to improve nuclease mediated homologous recombination, Administrative suppl$313,344
R42 · FY2022 · GM · contact PI
BAF60c and abdominal aortic aneurysm$543,752
R01 · FY2021 · HL · contact PI
Kruppel-like factor 11 (KLF11) and atherosclerosis$453,529
R01 · FY2021 · HL · contact PI
Kruppel-like factor 11 (KLF11) and atherosclerosis$453,529
R01 · FY2020 · HL · contact PI
Kruppel-like factor 11 (KLF11) and atherosclerosis$453,529
R01 · FY2019 · HL · contact PI
Kruppel-like factor 11 (KLF11) and atherosclerosis$453,045
R01 · FY2018 · HL · contact PI
Kruppel-like factor 11 (KLF11) and atherosclerosis$450,622
R01 · FY2017 · HL · contact PI
Novel methods to improve nuclease mediated homologous recombination$225,000
R41 · FY2017 · GM · contact PI
improving Cas9 mediated homologous recombination in pluripotent stem cells$224,518
R41 · FY2016 · GM · contact PI